Nationwide Fund Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-4,345
Closed -$77K 1593
2017
Q3
$77K Hold
4,345
﹤0.01% 2979
2017
Q2
$49K Hold
4,345
﹤0.01% 3056
2017
Q1
$56K Sell
4,345
-589
-12% -$7.59K ﹤0.01% 2967
2016
Q4
$108K Buy
4,934
+2,833
+135% +$62K ﹤0.01% 2854
2016
Q3
$44K Buy
+2,101
New +$44K ﹤0.01% 3062